Barbara Lysy

882 total citations · 1 hit paper
7 papers, 568 citations indexed

About

Barbara Lysy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Barbara Lysy has authored 7 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Barbara Lysy's work include Prostate Cancer Treatment and Research (5 papers), Protein Degradation and Inhibitors (3 papers) and Cancer-related gene regulation (2 papers). Barbara Lysy is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Protein Degradation and Inhibitors (3 papers) and Cancer-related gene regulation (2 papers). Barbara Lysy collaborates with scholars based in United States and China. Barbara Lysy's co-authors include Sarki A. Abdulkadir, Kenji Unno, Rajita Vatapalli, Young A. Yoo, Vinay Sagar, Yara Rodríguez, Zachary R. Chalmers, Huiying Han, Jonathan F. Anker and Hanlin Mok and has published in prestigious journals such as Nature Communications, JNCI Journal of the National Cancer Institute and Cancer Cell.

In The Last Decade

Barbara Lysy

7 papers receiving 566 citations

Hit Papers

Small-Molecule MYC Inhibitors Suppress Tumor Growth and E... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Lysy United States 7 380 192 150 96 79 7 568
Yara Rodríguez United States 10 394 1.0× 175 0.9× 102 0.7× 107 1.1× 79 1.0× 12 581
Jason P.W. Carey United States 12 386 1.0× 307 1.6× 111 0.7× 101 1.1× 63 0.8× 13 582
Katherine R. Singleton United States 11 497 1.3× 209 1.1× 190 1.3× 135 1.4× 38 0.5× 16 652
Roza Zandi Denmark 7 324 0.9× 264 1.4× 91 0.6× 103 1.1× 37 0.5× 9 540
Dongyin Yu United States 7 498 1.3× 194 1.0× 82 0.5× 151 1.6× 57 0.7× 9 685
Keiichiro Sakuma Japan 11 404 1.1× 126 0.7× 78 0.5× 89 0.9× 165 2.1× 19 567
Thanh Von United States 10 628 1.7× 289 1.5× 168 1.1× 110 1.1× 45 0.6× 11 808
Jennifer R. Devlin Australia 11 577 1.5× 222 1.2× 82 0.5× 120 1.3× 53 0.7× 16 734
Filipe Pinto Portugal 12 334 0.9× 109 0.6× 85 0.6× 128 1.3× 101 1.3× 24 479
Tatiana S. Gerashchenko Russia 12 188 0.5× 226 1.2× 92 0.6× 160 1.7× 125 1.6× 37 502

Countries citing papers authored by Barbara Lysy

Since Specialization
Citations

This map shows the geographic impact of Barbara Lysy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Lysy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Lysy more than expected).

Fields of papers citing papers by Barbara Lysy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Lysy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Lysy. The network helps show where Barbara Lysy may publish in the future.

Co-authorship network of co-authors of Barbara Lysy

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Lysy. A scholar is included among the top collaborators of Barbara Lysy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Lysy. Barbara Lysy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rodríguez, Yara, Kenji Unno, Mihai I. Truica, et al.. (2022). A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer. Cancer Research. 82(11). 2110–2123. 24 indexed citations
2.
Unno, Kenji, Zachary R. Chalmers, Sahithi Pamarthy, et al.. (2021). Activated ALK Cooperates with N-Myc via Wnt/β-Catenin Signaling to Induce Neuroendocrine Prostate Cancer. Cancer Research. 81(8). 2157–2170. 41 indexed citations
3.
Vatapalli, Rajita, Vinay Sagar, Yara Rodríguez, et al.. (2020). Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. Nature Communications. 11(1). 4153–4153. 77 indexed citations
4.
Han, Huiying, Atul D. Jain, Mihai I. Truica, et al.. (2019). Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy. Cancer Cell. 36(5). 483–497.e15. 302 indexed citations breakdown →
5.
Sagar, Vinay, Rajita Vatapalli, Barbara Lysy, et al.. (2019). EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells. Cell Death and Disease. 10(11). 801–801. 44 indexed citations
6.
Yoo, Young A., Rajita Vatapalli, Barbara Lysy, et al.. (2018). The Role of Castration-Resistant Bmi1+Sox2+ Cells in Driving Recurrence in Prostate Cancer. JNCI Journal of the National Cancer Institute. 111(3). 311–321. 31 indexed citations
7.
Yoo, Young A., Meejeon Roh, Barbara Lysy, et al.. (2016). Bmi1 marks distinct castration-resistant luminal progenitor cells competent for prostate regeneration and tumour initiation. Nature Communications. 7(1). 12943–12943. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026